3Vendrame M,Khurana DS,Cruz M,et al.Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy[J].Epilepsia,2007,48(11):2116-2120.
4Deshpande LS,Delorenzo RJ.Mechanisms of levetiracetam in the control of status epilepticus and epilepsy[J].Front Neurol,2014,5:11.
5Wright C,Downing J,Mungall D,et al.Clinical pharmacology and pharmacokinetics of levetiracetam[J].Front Neurol,2013,4:192.
6Elberry AA,Felemban RK,Hareeri RH,et al.Efficacy and safety of levetiracetam in pediatric epilepsy[J].Saudi Pharm J,2012,20(1):81-84.
7Vesoulis ZA,Mathur AM.Advances in management of neonatal seizures[J].Indian J Pediatr,2014,81(6):592-598.
8Goldberg-Stern H,Feldman L,Eidlitz-Markus T,et al.Levetiracetam in children,adolescents and young adults with intractable epilepsy:efficacy,tolerability and effect on electroencephalogram-a pilot study[J].Eur J Paediatr Neurol,2013,17(3):248-253.
9Halma E,de Louw AJ,Klinkenberg S,et al.Behavioral side-effects of levetiracetam in children with epilepsy:A systematic review[J].Seizure,2014,12:S1059-1311.
10Arhan E, Serdaroglu A, Kurt AN, et at. Drug treatment failtures and effectivity in children with newly diagnosed epilepsy. Seizure, 2010, 19(9):553-557.